Seino Y - Search Results

1

Favorable impact of growth hormone treatment on cholesterol levels in turner syndrome.

Kohno H, Igarashi Y, Ozono K, Ohyama K, Ogawa M, Osada H, Onigata K, Kanzaki S, Seino Y, Takahashi H, Tajima T, Tachibana K, Tanaka H, Nishi Y, Hasegawa T, Fujieda K, Fujita K, Horikawa R, Yokoya S, Yorifuji T, Tanaka T. Kohno H, et al. Among authors: seino y. Clin Pediatr Endocrinol. 2012 Apr;21(2):29-34. doi: 10.1297/cpe.21.29. Epub 2012 Mar 24. Clin Pediatr Endocrinol. 2012. PMID: 23926408 Free PMC article.

2

Phosphate administration enhances the action of 1,25(OH)2D3 in familial hypophosphatemic vitamin D resistant rickets.

Seino Y, Tanaka H, Yamaoka K. Seino Y, et al. J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:92-5. doi: 10.3177/jnsv.38.special_92. J Nutr Sci Vitaminol (Tokyo). 1992. PMID: 1338453 No abstract available.

3

1,25-Dihydroxyvitamin D3 stimulates the secretion of insulin-like growth factor binding protein 3 (IGFBP-3) by cultured human osteosarcoma cells.

Moriwake T, Tanaka H, Kanzaki S, Higuchi J, Seino Y. Moriwake T, et al. Among authors: seino y. Endocrinology. 1992 Feb;130(2):1071-3. doi: 10.1210/endo.130.2.1370789. Endocrinology. 1992. PMID: 1370789

4

Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy.

Kanzaki S, Hosoda K, Moriwake T, Tanaka H, Kubo T, Inoue M, Higuchi J, Yamaji T, Seino Y. Kanzaki S, et al. Among authors: seino y. J Clin Endocrinol Metab. 1992 Oct;75(4):1104-9. doi: 10.1210/jcem.75.4.1400878. J Clin Endocrinol Metab. 1992. PMID: 1400878

5

1,25-Dihydroxyvitamin D3 enhances the effect of refeeding on steady state preproinsulin messenger ribonucleic acid levels in rats.

Ozono K, Seino Y, Yano H, Yamaoka K, Seino Y. Ozono K, et al. Among authors: seino y. Endocrinology. 1990 Apr;126(4):2041-5. doi: 10.1210/endo-126-4-2041. Endocrinology. 1990. PMID: 2180682

6

Analysis of linear growth in survivors of childhood acute lymphoblastic leukemia.

Yamashita N, Tanaka H, Moriwake T, Nishiuchi R, Oda M, Seino Y. Yamashita N, et al. Among authors: seino y. J Bone Miner Metab. 2003;21(3):172-8. doi: 10.1007/s007740300027. J Bone Miner Metab. 2003. PMID: 12720052

7

Efficacy of growth hormone therapy for patients with skeletal dysplasia.

Kanazawa H, Tanaka H, Inoue M, Yamanaka Y, Namba N, Seino Y. Kanazawa H, et al. Among authors: seino y. J Bone Miner Metab. 2003;21(5):307-10. doi: 10.1007/s00774-003-0425-7. J Bone Miner Metab. 2003. PMID: 12928832 Clinical Trial.

8

PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation.

Yamanaka Y, Tanaka H, Koike M, Nishimura R, Seino Y. Yamanaka Y, et al. Among authors: seino y. J Bone Miner Res. 2003 Aug;18(8):1395-403. doi: 10.1359/jbmr.2003.18.8.1395. J Bone Miner Res. 2003. PMID: 12929929 Free article.

9

Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.

Koike M, Yamanaka Y, Inoue M, Tanaka H, Nishimura R, Seino Y. Koike M, et al. Among authors: seino y. J Bone Miner Res. 2003 Nov;18(11):2043-51. doi: 10.1359/jbmr.2003.18.11.2043. J Bone Miner Res. 2003. PMID: 14606518 Free article.

10

Molecular basis for the treatment of achondroplasia.

Yamanaka Y, Ueda K, Seino Y, Tanaka H. Yamanaka Y, et al. Among authors: seino y. Horm Res. 2003;60 Suppl 3:60-4. doi: 10.1159/000074503. Horm Res. 2003. PMID: 14671399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,496 results

Search Page

Filters